Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension
Metadatos
Mostrar el registro completo del ítemAutor
Gruber, Tim; Pan, Chenchen; Contreras, Raian Eduardo; Wiedemann, Tobias; Morgan, Donald A.; Skowronski, Alicja A.; lefort, Sandrine; Murat, Cahué De Bernadis; Le Thuc, Ophelia; Legutko, Beata; Ruiz Ojeda, Francisco Javier; Fuente-Fernández, María de la; García-Villalón, Ángel Luis; González-Hedstöm, Daniel; Huber, Melanie; Szigeti-Buck, Klara; Müller, Timo D.; Ussar, Siegfried; Pfluger, Paul; Woods, Steve C.; Ertück, Ali; LeDuc, Charles A.; Rahmouni, Kamal; Granado, Miriam; Horvarth, Tamas L.; Tschöp, Matthias H.Editorial
Elsevier
Fecha
2021-06-01Referencia bibliográfica
Gruber T, Pan C, Contreras RE, Wiedemann T, Morgan DA, Skowronski AA, Lefort S, De Bernardis Murat C, Le Thuc O, Legutko B, Ruiz-Ojeda FJ, Fuente-Fernández M, García-Villalón AL, González-Hedström D, Huber M, Szigeti-Buck K, Müller TD, Ussar S, Pfluger P, Woods SC, Ertürk A, LeDuc CA, Rahmouni K, Granado M, Horvath TL, Tschöp MH, García-Cáceres C. Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension. Cell Metab. 2021 Jun 1;33(6):1155-1170.e10. doi: 10.1016/j.cmet.2021.04.007
Patrocinador
Marie Skłodowska-Curie (ChroMe # 675610); European Research Council (Hypoflam # 695054, AstroNeuroCrosstalk #757393); German Research Foundation (EXC 2145 SyNergy – ID 390857198, SFB TRR152/P23, SFB TRR296); US National Institutes of Health (HL084207); University of Iowa (merit grant BX004249); Iowa Neuroscience Institute; German Excellence Initiative/European Union Seventh Framework Programme 291763Resumen
Pathologies of the micro- and macrovascular systems are a hallmark of the metabolic syndrome, which can lead to chronically elevated blood pressure. However, the underlying pathomechanisms involved still need to be clarified. Here, we report that an obesity-associated increase in serum leptin triggers the select expansion of the micro-angioarchitecture in pre-autonomic brain centers that regulate hemodynamic homeostasis. By using a series of cell- and region-specific loss- and gain-of-function models, we show that this pathophysiological process depends on hypothalamic astroglial hypoxia-inducible factor 1α-vascular endothelial growth factor (HIF1α-VEGF) signaling downstream of leptin signaling. Importantly, several distinct models of HIF1α-VEGF pathway disruption in astrocytes are protected not only from obesity-induced hypothalamic angiopathy but also from sympathetic hyperactivity or arterial hypertension. These results suggest that hyperleptinemia promotes obesity-induced hypertension via a HIF1α-VEGF signaling cascade in hypothalamic astrocytes while establishing a novel mechanistic link that connects hypothalamic micro-angioarchitecture with control over systemic blood pressure.





